autoimmune diseases
Showing NaN - NaN of 9
Scleroderma, Diffuse, Scleroderma, Systemic, Scleroderma, Limited Trial in India, United States (Oral Ifetroban, Oral Placebo)
Recruiting
- Scleroderma, Diffuse
- +7 more
- Oral Ifetroban
- Oral Placebo
-
Tucson, Arizona
- +15 more
Jun 30, 2022
PANDAS, Anxiety Disorder, Autoimmune Diseases Trial in Boston (Naproxen Sodium, Placebo)
Recruiting
- PANDAS
- +3 more
- Naproxen Sodium
- Placebo
-
Boston, MassachusettsMassachusetts General Hospital
Feb 14, 2022
Autoimmune Diseases, Systemic Inflammatory Process, Knee Pain Chronic Trial in Boston (drug, dietary supplement, other)
Active, not recruiting
- Autoimmune Diseases
- +4 more
- Fish Oil
- +2 more
-
Boston, MassachusettsBrigham and Women's Hospital
Mar 15, 2021
Neurological Disorder, Autoimmune Diseases Trial in Canada, United States (Mycophenolate Mofetil, Azathioprine)
Completed
- Neurological Disorder
- Autoimmune Diseases
- Mycophenolate Mofetil
- Azathioprine
-
Palo Alto, California
- +18 more
Feb 2, 2021
Chemical Injuries, Unspecified Complication of Corneal Transplant, Autoimmune Diseases Trial in Boston (Riboflavin)
Completed
- Chemical Injuries
- +7 more
-
Boston, MassachusettsMassachusetts Eye and Ear Infirmary
Oct 18, 2019
Chronic Kidney Disease, Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL) Trial in Boston (Haploidentical Bone
Unknown status
- Chronic Kidney Disease
- +16 more
- Haploidentical Bone Marrow/Kidney
-
Boston, MassachusettsMassachusetts General Hospital
Mar 21, 2017
Autoimmune Diseases, Multiple Sclerosis Trial in Boston (Glatiramer acetate, Albuterol, Albuterol )
Completed
- Autoimmune Diseases
- Multiple Sclerosis
- Glatiramer acetate
- +2 more
-
Boston, MassachusettsBrigham and Women's Hospital/Harvard Medical School
Sep 20, 2016
Immunologic Diseases, Autoimmune Diseases, Systemic Lupus Erythematosus Trial in Worldwide (Abetimus sodium (LJP 394))
Completed
- Immunologic Diseases
- +4 more
- Abetimus sodium (LJP 394)
-
Birmingham, Alabama
- +81 more
Sep 22, 2006